MENU
+Compare
TCRT
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$4.22
Change
+$1.42 (+50.71%)
Capitalization
6.61M

TCRT Alaunos Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy... Show more

Industry: #Biotechnology
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TCRT with price predictions
Apr 02, 2025

TCRT in +90.48% Uptrend, rising for three consecutive days on April 02, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TCRT advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 25, 2025. You may want to consider a long position or call options on TCRT as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TCRT just turned positive on March 21, 2025. Looking at past instances where TCRT's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

TCRT moved above its 50-day moving average on April 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TCRT crossed bullishly above the 50-day moving average on April 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where TCRT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCRT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TCRT broke above its upper Bollinger Band on April 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TCRT entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.428) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (64.103) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TCRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TCRT is expected to report earnings to rise 1,025.00% to -44 cents per share on March 05

Alaunos Therapeutics Inc. TCRT Stock Earnings Reports
Q4'23
Est.
$-0.45
Q3'23
Est.
$-0.04
Q2'23
Est.
$-0.04
Q1'23
Est.
$-0.04
Q4'22
Beat
by $0.01
The last earnings report on November 14 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 6.36M shares outstanding, the current market capitalization sits at 6.61M.
A.I. Advisor
published General Information

General Information

a cancer treatment company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONVO2.170.03
+1.40%
Organovo Holdings Inc
UHS188.73-0.05
-0.03%
Universal Health Services
NKTR0.60-0.06
-8.88%
Nektar Therapeutics
MIR13.64-1.39
-9.25%
Mirion Technologies
BRY2.78-0.30
-9.74%
Berry Corp

TCRT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
+47.50%
SNTI - TCRT
47%
Loosely correlated
-6.54%
REVB - TCRT
46%
Loosely correlated
+5.24%
BRTX - TCRT
33%
Loosely correlated
-1.08%
ALNY - TCRT
30%
Poorly correlated
-1.70%
AGEN - TCRT
30%
Poorly correlated
-1.84%
More